Urinary 8-hydroxy-2′-deoxyguanosine (8-OHdG) and genetic polymorphisms in breast cancer patients

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 631, Issue 1, 2007, Pages 62-68

  Kuo, Hsien Wen ^a   Chou, Sze Yuan ^a,b   Hu, Tsung Wen ^a   Wu, Fang Yang ^a   Chen, Da Jen ^c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHENG CHING GENERAL HOSPITAL   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

8 OHdG levels; Breast cancer; Polymorphisms; Urine

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ARYLAMINE ACETYLTRANSFERASE; CYTOCHROME P450 1A1; CYTOCHROME P450 1M1; CYTOCHROME P450 ISOENZYME; ORAL CONTRACEPTIVE AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER PATIENT; CANCER STAGING; CARCINOGENESIS; CIGARETTE SMOKING; COFFEE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE COURSE; FEMALE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; PRIORITY JOURNAL; STATISTICAL MODEL; URINALYSIS;

ADULT; ARYLAMINE N-ACETYLTRANSFERASE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; DEOXYGUANOSINE; DNA DAMAGE; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, GENETIC; REACTIVE OXYGEN SPECIES;

EID: 34249303104     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2007.04.009     Document Type: Article

References (33)

1. Department of Health. Status of Health Statistics in Taiwan (2005), Taiwan Department of Health
2. Benz C.C., Atsriku C., Yau C., Britton D., Schilling B., Gibson B.W., Baldwin M.A., and Scott G.K. Novel pathways associated with quinone-induced stress in breast cancer cells. Drug Metab. Rev. 38 (2006) 601-613
3. Malins D.C., Anderson K.M., Jaruga P., Ramsey C.R., Gilman N.K., Green V.M., Rostad S.W., Emerman J.T., and Dizdaroglu M. Oxidative changes in the DNA of stroma and epithelium from the female breast: potential implications for breast cancer. Cell Cycle 5 (2006) 1629-1632
4. Nagashima M., Tsuda H., Takenoshita S., Nagamachi Y., Hirohashi S., Yokota J., and Kasai H. 8-Hydroxy-2′-deoxyguanosinelevels in DNA of human breast cancers are not significantly different from those of non-cancerous breast tissues by the HPLC-ECD method. Cancer Lett. 90 (1995) 157-162
5. Musarrat J., Arezina-Wilson J., and Wani A.A. Prognostic and aetiological relevance of 8-hydroxydeoxyguanosine in human breast carcinogenesis. Euro. J. Cancer 32 (1996) 1209-1214
6. Kuchino Y., Mori F., Kasai H., Inoue H., Iwai S., Miura K., Ohtsuka E., and Nishimura S. Misreading of DNA template containing 8-hydroxy-2′-deoxyguanosine at the modified base and at adjacent residue. Nature 327 (1987) 77-79
7. Liehr J.G. Dual role estrogens as hormones and pro-carcinogens: tumor initiation by metabolic activation of estrogens. Euro. J. Cancer Prev. 6 (1997) 3-10
8. Matsui A., Ikeda T., Enomoto K., Hosoda K., Nakashima H., Omae K., Watanabe M., Hibi T., and Kitajima M. Increased formation of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes. Cancer Lett. 151 (2000) 87-95
9. Egan K.M., Cai Q., Shu X.O., Jin F., Zhu T.L., Dai Q., Gao Y.T., and Zheng W. Genetic polymorphisms in GSTM1, GSTP1, and GSTT1 and the risk for breast cancer: results from the Shanghai Breast Cancer Study and meta-analysis. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 197-204
10. Chacko P., Joseph T., Mathew B.S., Rajan B., and Pillai M.R. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome. Mutat. Res. 581 (2005) 153-163
11. Germadnik D., Pilger A., and Rudiger H.W. Assay for the determination of urinary 8-hydroxydeoxyguanosine by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. B 689 (1997) 399-403
12. Loft S., Vistisen K., Ewertz M., Overvad K., and Poulsen H.E. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in human: influence of smoking, gender and body mass index. Carcinogenesis 13 (1992) 2241-2247
13. Kawajiri K., Nakachi K., Imai K., Yoshii A., Shinoda N., and Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501AI gene. FEBS Lett. 263 (1990) 131-133
14. Comstock K.E., Sanderson B.J.S., Claflin G., and Henner W.D. GST1 gene deletion determined by polymerase chain reaction. Nucl. Acid Res. 18 (1990) 3670
15. Pemble S., Schroeder K.R., Spencer S.R., Meyer D.J., Hallier E., Bolt H.M., Ketterer B., and Taylor J.B. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem. J. 300 (1994) 271-276
16. Ambrosone C.B., Freudenheim J.L., Graham S., Marshall J.R., Vena J.E., Brasure J.R., Michalek A.M., Laughlin R., Nemoto T., Gillenwater K.A., Harrington A.M., and Shields P.G. Cigarette smoking, N-acetyltransferase genetic polymorphisms, and breast cancer risk. JAMA 276 (1996) 1494-1501
17. Tominaga S., and Kuroishi T. Epidemiology of breast cancer in Japan. Cancer Lett. 90 (1995) 75-79
18. Lee M.M., Chang I.Y., Horng C.F., Chang J.S., Cheng S.H., and Huang A. Breast cancer and dietary factors in Taiwanese women. Cancer Causes Control 16 (2005) 929-937
19. Chie W.C., Chen C.E., Lee W.C., Chen C.J., and Lin R.S. Age-period-cohort analysis of breast cancer mortality. Anticancer Res. 15 (1995) 511-515
20. Chie W.C., Li C.Y., Huang C.S., Chang K.J., Yen M.L., and Lin R.S. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives. Int. J. Cancer 77 (1998) 219-223
21. Nutter L.M., Wu Y.Y., Ngo E.O., Sierra E.E., Gutierrez P.L., and Abul-Hajj Y.J. An o-quinone form of estrogen produces free radicals in human breast cancer cells: correlation with DNA damage. Chem. Res. Toxicol. 7 (1994) 23-28
22. Murrell T.G. Epidemiological and biochemical support for a theory on the cause and prevention of breast cancer. Med. Hypoth. 36 (1991) 389-396
23. Liehl J.G. Genotoxic effects of estrogen. Mutat. Res. 238 (1990) 269-276
24. Fraga C.G., Shigenga M.K., Park J.W., Degan P., and Ames B.N. Oxidative damage to DNA during aging: 8-hydroxy-2′-deoxyguanosine in rat organ DNA and urine. Proc. Natl. Acad. Sci. 87 (1990) 4533-4537
25. Honda M., Yamada Y., Tomonaga M., Ichinose H., and Kamihira S. Correlation of urinary 8-hydroxy-2′-deoxyguanosine (8-OHdG), a biomarker of oxidative DNA damage, and clinical features of hematological disorders: a pilot study. Leuk. Res. 24 (2000) 461-468
26. Malins D.C., Holmes E.H., Polissar N.L., and Gunselman S.J. The etiology of breast cancer. Cancer 71 (1993) 3036-3043
27. Thomson C.A., Giuliano A.R., Shaw J.W., Rock C.L., Ritenbaugh C.K., Hakim I.A., Hollenbach K.A., Alberts D.S., and Pierce J.P. Diet and biomarkers of oxidative damage in women previously treated for breast cancer. Nutr. Cancer 51 (2005) 146-154
28. Curran J.E., Weinstein S.R., and Griffiths L.R. Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer susceptibility. Cancer Lett. 153 (2000) 113-120
29. Helzlsouer K.J., Selmin O., Huang H., Strickland P.T., Hoffman S., Alberg A.J., Watson M., Comstock G.W., and Bell D. Association between glutathione S-transferases M1, P1 and T1 genetic polymorphisms and development of breast cancer. J. Natl. Cancer Inst. 90 (1998) 512-518
30. Zhong S., Wyllie A.H., Barnes D., Wolf C.R., and Spurr N.K. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14 (1994) 1821-1824
31. Gallicchio L., Berndt S.I., McSorley M.A., Newschaffer C.J., Thuita L.W., Argani P., Hoffman S.C., and Helzlsouer K.J. Polymorphisms in estrogen-metabolizing and estrogen receptor genes and the risk of developing breast cancer among a cohort of women with benign breast disease. BMC Cancer 173 (2006) 6
32. Morabia A., Bernstein M.S., Bouchardy I., Kurtz J., and Morris M.A. Breast cancer and active and passive smoking: the role of the N-acetyltransferase genotype. Am. J. Epdiemiol. 152 (2000) 226-232
33. Chen D.C., Chung Y.F., Yeh Y.T., Chaung H.C., Kuo F.C., Fu O.Y., Chen H.Y., Hou M.F., and Yuan S.S. Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett. 237 (2006) 109-114